303 related articles for article (PubMed ID: 16787229)
1. Endocannabinoids in appetite control and the treatment of obesity.
Kirkham TC; Tucci SA
CNS Neurol Disord Drug Targets; 2006 Jun; 5(3):272-92. PubMed ID: 16787229
[TBL] [Abstract][Full Text] [Related]
2. [Endocannabinoid system and energy metabolism: physiology and pathophysiology].
Pagotto U; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):74S-82S. PubMed ID: 18773754
[TBL] [Abstract][Full Text] [Related]
3. Endocannabinoid control of food intake and energy balance.
Di Marzo V; Matias I
Nat Neurosci; 2005 May; 8(5):585-9. PubMed ID: 15856067
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinoids and food intake: newborn suckling and appetite regulation in adulthood.
Fride E; Bregman T; Kirkham TC
Exp Biol Med (Maywood); 2005 Apr; 230(4):225-34. PubMed ID: 15792943
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoids in the regulation of appetite and body weight.
Kirkham TC
Behav Pharmacol; 2005 Sep; 16(5-6):297-313. PubMed ID: 16148436
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.
Vemuri VK; Janero DR; Makriyannis A
Physiol Behav; 2008 Mar; 93(4-5):671-86. PubMed ID: 18155257
[TBL] [Abstract][Full Text] [Related]
7. The endocannabinoid system: physiology and pharmacology.
Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
[TBL] [Abstract][Full Text] [Related]
8. Endocannabinoids and food consumption: comparisons with benzodiazepine and opioid palatability-dependent appetite.
Cooper SJ
Eur J Pharmacol; 2004 Oct; 500(1-3):37-49. PubMed ID: 15464019
[TBL] [Abstract][Full Text] [Related]
9. The endocannabinoid system: a new target for the regulation of energy balance and metabolism.
Després JP
Crit Pathw Cardiol; 2007 Jun; 6(2):46-50. PubMed ID: 17667864
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid receptors as therapeutic targets for obesity and metabolic diseases.
Bellocchio L; Mancini G; Vicennati V; Pasquali R; Pagotto U
Curr Opin Pharmacol; 2006 Dec; 6(6):586-91. PubMed ID: 17027338
[TBL] [Abstract][Full Text] [Related]
11. The emerging role of the endocannabinoid system in endocrine regulation and energy balance.
Pagotto U; Marsicano G; Cota D; Lutz B; Pasquali R
Endocr Rev; 2006 Feb; 27(1):73-100. PubMed ID: 16306385
[TBL] [Abstract][Full Text] [Related]
12. Metabotropic suppression of excitation in murine autaptic hippocampal neurons.
Straiker A; Mackie K
J Physiol; 2007 Feb; 578(Pt 3):773-85. PubMed ID: 17110416
[TBL] [Abstract][Full Text] [Related]
13. Minireview: Endocannabinoids and their receptors as targets for obesity therapy.
de Kloet AD; Woods SC
Endocrinology; 2009 Jun; 150(6):2531-6. PubMed ID: 19372200
[TBL] [Abstract][Full Text] [Related]
14. Retrograde signalling by endocannabinoids.
Vaughan CW; Christie MJ
Handb Exp Pharmacol; 2005; (168):367-83. PubMed ID: 16596781
[TBL] [Abstract][Full Text] [Related]
15. The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use.
Xie S; Furjanic MA; Ferrara JJ; McAndrew NR; Ardino EL; Ngondara A; Bernstein Y; Thomas KJ; Kim E; Walker JM; Nagar S; Ward SJ; Raffa RB
J Clin Pharm Ther; 2007 Jun; 32(3):209-31. PubMed ID: 17489873
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration.
Basavarajappa BS; Nixon RA; Arancio O
Mini Rev Med Chem; 2009 Apr; 9(4):448-62. PubMed ID: 19356123
[TBL] [Abstract][Full Text] [Related]
17. Role of the endocannabinoid system in management of patients with type 2 diabetes mellitus and cardiovascular risk factors.
Davis SN; Perkins JM
Endocr Pract; 2007; 13(7):790-804. PubMed ID: 18194939
[TBL] [Abstract][Full Text] [Related]
18. Rehashing endocannabinoid antagonists: can we selectively target the periphery to safely treat obesity and type 2 diabetes?
Patti ME
J Clin Invest; 2010 Aug; 120(8):2646-8. PubMed ID: 20664166
[TBL] [Abstract][Full Text] [Related]
19. Role of the endocannabinoid system in energy balance regulation and obesity.
Cota D
Front Horm Res; 2008; 36():135-145. PubMed ID: 18230900
[TBL] [Abstract][Full Text] [Related]
20. [The endocannabinoid system].
Sudano I; Périat D; Noll G
Praxis (Bern 1994); 2008 Apr; 97(7):375-80. PubMed ID: 18548817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
